| IMM Stock | | | 1.12 0.01 0.88% |
ImmuPharma PLC financial indicator trend analysis is infinitely more than just investigating ImmuPharma PLC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ImmuPharma PLC is a good investment. Please check the relationship between ImmuPharma PLC Cost Of Revenue and its Net Income accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmuPharma PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
Cost Of Revenue vs Net Income
Cost Of Revenue vs Net Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
ImmuPharma PLC Cost Of Revenue account and
Net Income. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between ImmuPharma PLC's Cost Of Revenue and Net Income is 0.56. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Net Income in the same time period over historical financial statements of ImmuPharma PLC, assuming nothing else is changed. The correlation between historical values of ImmuPharma PLC's Cost Of Revenue and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of ImmuPharma PLC are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Cost Of Revenue i.e., ImmuPharma PLC's Cost Of Revenue and Net Income go up and down completely randomly.
Correlation Coefficient | 0.56 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Cost Of Revenue
Cost of Revenue is found on ImmuPharma PLC income statement and represents the costs associated with goods and services ImmuPharma PLC provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in ImmuPharma PLC financial statement analysis. It represents the amount of money remaining after all of ImmuPharma PLC operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most indicators from ImmuPharma PLC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ImmuPharma PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmuPharma PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
The current year's
Selling General Administrative is expected to grow to about 1.7
M, whereas
Tax Provision is forecasted to decline to (522
K).
ImmuPharma PLC fundamental ratios Correlations
Click cells to compare fundamentals
ImmuPharma PLC Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ImmuPharma PLC fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in ImmuPharma Stock
Balance Sheet is a snapshot of the
financial position of ImmuPharma PLC at a specified time, usually calculated after every quarter, six months, or one year. ImmuPharma PLC Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of ImmuPharma PLC and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which ImmuPharma currently owns. An asset can also be divided into two categories, current and non-current.